These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11394640)

  • 21. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
    Young IR; Chan EC; Smith R; Chrousos GP; Veldhuis JD; Canny BJ
    Neuroendocrinology; 2002 Jul; 76(1):47-54. PubMed ID: 12097816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
    Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
    Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does estradiol treatment normalize the hypothalamic-pituitary-adrenal axis in streptozotocin-induced ovariectomized diabetic female rats?
    Elkind-Hirsch KE; Valdes CT; Rogers DG
    Horm Metab Res; 1991 Oct; 23(10):481-5. PubMed ID: 1761279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and neuroendocrine actions of the Met-enkephalin-related peptide MERF.
    Bujdosó E; Jászberényi M; Farkas J; Tóth G; Wollemann M; Telegdy G
    Horm Behav; 2003 Feb; 43(2):302-11. PubMed ID: 12694640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
    Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone.
    Akana SF; Scribner KA; Bradbury MJ; Strack AM; Walker CD; Dallman MF
    Endocrinology; 1992 Aug; 131(2):585-94. PubMed ID: 1322275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential behavioral and endocrinological effects of corticotropin-releasing hormone (CRH) in the Syracuse high- and low-avoidance rats.
    Gupta P; Brush FR
    Horm Behav; 1998 Dec; 34(3):262-7. PubMed ID: 9878275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
    Spinedi E; Gaillard RC
    J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral effects to alpha-melanocyte-stimulating hormone.
    Vecsernyés M; Biró E; Gardi J; Julesz J; Telegdy G
    Endocr Res; 2000 Aug; 26(3):347-56. PubMed ID: 11019900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal thymulin gene therapy in nude mice: Effects on the morphology of the pituitary corticotrope population.
    Martines E; Reggiani PC; Schwerdt JI; Goya RG; Cónsole G
    Histol Histopathol; 2011 Apr; 26(4):471-9. PubMed ID: 21360440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone.
    Payne LC; Weigent DA; Blalock JE
    Biochem Biophys Res Commun; 1994 Jan; 198(2):480-4. PubMed ID: 8297358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary-adrenal response in neonatal rats.
    Guillet R; Saffran M; Michaelson SM
    Endocrinology; 1980 Mar; 106(3):991-4. PubMed ID: 6243561
    [No Abstract]   [Full Text] [Related]  

  • 39. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.